7.3119
price down icon0.52%   -0.0381
 
loading
Galecto Inc stock is traded at $7.3119, with a volume of 14,311. It is down -0.52% in the last 24 hours and up +96.56% over the past month. Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
See More
Previous Close:
$7.35
Open:
$7.2
24h Volume:
14,311
Relative Volume:
0.01
Market Cap:
$9.68M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-5.0427
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
-13.26%
1M Performance:
+96.56%
6M Performance:
+161.14%
1Y Performance:
+6.74%
1-Day Range:
Value
$7.18
$7.4941
1-Week Range:
Value
$7.02
$8.355
52-Week Range:
Value
$2.01
$31.70

Galecto Inc Stock (GLTO) Company Profile

Name
Name
Galecto Inc
Name
Phone
45-70-70-52-10
Name
Address
75 STATE STREET, BOSTON
Name
Employee
5
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
GLTO's Discussions on Twitter

Compare GLTO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GLTO
Galecto Inc
7.31 9.74M 0 -38.35M -36.91M -1.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.76 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
655.00 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.91 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
813.02 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
190.00 41.29B 398.11M -1.03B -868.57M -5.7032

Galecto Inc Stock (GLTO) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-26-21 Resumed Credit Suisse Outperform
Nov-23-20 Initiated BofA Securities Buy
Nov-23-20 Initiated Credit Suisse Outperform
Nov-23-20 Initiated SVB Leerink Outperform

Galecto Inc Stock (GLTO) Latest News

pulisher
06:55 AM

Can Galecto Inc. stock weather global recessionJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com

06:55 AM
pulisher
05:31 AM

Combining price and volume data for Galecto Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - newser.com

05:31 AM
pulisher
12:51 PM

How to monitor Galecto Inc. with trend dashboardsQuarterly Earnings Summary & Safe Entry Zone Identification - newser.com

12:51 PM
pulisher
12:36 PM

Will Galecto Inc. stock maintain dividend yieldTrade Entry Report & Weekly Chart Analysis and Guides - newser.com

12:36 PM
pulisher
Oct 30, 2025

Is a relief rally coming for Galecto Inc. holdersJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can Galecto Inc. stock hit analyst price targetsTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Galecto Inc. stock cheap at current valuationQuarterly Growth Report & High Accuracy Investment Entry Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Galecto Inc. stock remains undervalued2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Is Galecto Inc. stock attractive for income investorsJuly 2025 Update & Growth Oriented Trading Recommendations - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Using portfolio simulators with Galecto Inc. includedQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What drives Galecto Inc stock priceRisk-Reward Ratio Analysis & Access Free Tools and Start Investing - earlytimes.in

Oct 27, 2025
pulisher
Oct 26, 2025

Is Galecto Inc. stock attractive for growth ETFsTrade Volume Summary & Verified Swing Trading Watchlist - newser.com

Oct 26, 2025

Galecto Inc Stock (GLTO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Galecto Inc Stock (GLTO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Winslow Garrett
General Counsel
Jul 03 '25
Sale
3.39
260
881
1,429
Firmani Lori
Interim CFO
Jul 03 '25
Sale
3.39
147
498
692
Winslow Garrett
General Counsel
Jan 03 '25
Sale
5.60
471
2,638
1,009
Firmani Lori
Interim CFO
Jan 03 '25
Sale
5.63
261
1,469
465
Schambye Hans T.
Chief Executive Officer
Jan 03 '25
Sale
5.60
1,341
7,510
3,397
$37.41
price up icon 1.19%
$28.43
price down icon 0.89%
$93.47
price up icon 0.99%
$102.73
price down icon 1.84%
biotechnology ONC
$309.38
price up icon 0.38%
$189.98
price down icon 2.26%
Cap:     |  Volume (24h):